BMS707035

BMS707035 Basic information
Product Name:BMS707035
Synonyms:BMS707035;CS-455;BMS 707035;BMS707035;2-(1,1-DIOXOTHIAZINAN-2-YL)-N-[(4-FLUOROPHENYL)METHYL]-5-HYDROXY-1-METHYL-6-OXOPYRIMIDINE-4-CARBOXAMIDE;N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)-4-pyrimidinecarboxamide;4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin;4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)-;BMS707035 USP/EP/BP
CAS:729607-74-3
MF:C17H19FN4O5S
MW:410.42
EINECS:
Product Categories:Inhibitors;Inhibitor
Mol File:729607-74-3.mol
BMS707035 Structure
BMS707035 Chemical Properties
density 1.54
storage temp. Store at -20°C
solubility insoluble in EtOH; insoluble in H2O; ≥41 mg/mL in DMSO
form Powder
pka4.50±1.00(Predicted)
Safety Information
MSDS Information
BMS707035 Usage And Synthesis
UsesBMS-707035 is a specific HIV-I integrase (IN) inhibitor.
targetHIV-I integrase
BMS707035 Preparation Products And Raw materials
Elvitegravir MK-2048 Raltegravir Saracatinib GSK1349572 Dapagliflozin 4-Aminodiphenylamine Acetanilide

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.